JPMorgan analyst Richard Choe raised the firm’s price target on American Tower (AMT) to $255 from $250 and keeps an Overweight rating on the shares. The firm moved its price target to December 2026 from 2025 post the company’s Q2 report. American Tower is seeing “healthy” activity from its carrier customers and application volumes, but there has been a delay into revenue generation, which reduced the company’s outlook, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMT:
- HSBC downgrades American Tower on valuation after Q2 report
- American Tower downgraded to Hold from Buy at HSBC
- American Tower: Strong International Growth and Raised Guidance Justify Buy Rating Despite Mixed Q2 2025 Results
- American Tower’s Earnings Call: Positive Outlook Amid Challenges
- American Tower price target lowered to $245 from $250 at BMO Capital